[
  {
    "check": "sample_size",
    "name": "Sample size",
    "category": "LOGICAL",
    "expected": "254",
    "actual": "254",
    "passed": true,
    "message": "Expected ~254 subjects, got 254"
  },
  {
    "check": "arm_balance",
    "name": "Treatment arm balance",
    "category": "LOGICAL",
    "expected": "~84-86 per arm",
    "actual": "86/84/84",
    "passed": true,
    "message": "Arm sizes: Placebo=86, Xan Low=84, Xan High=84"
  },
  {
    "check": "age_range",
    "name": "Age range",
    "category": "RANGE",
    "expected": "50-90 years (elderly Alzheimer's)",
    "actual": "54-89",
    "passed": true,
    "message": "Age range: 54 to 89 years"
  },
  {
    "check": "sex_distribution",
    "name": "Sex distribution",
    "category": "RANGE",
    "expected": "~44% male, ~56% female",
    "actual": "41% male",
    "passed": true,
    "message": "Male: 40.6%"
  },
  {
    "check": "mmse_range",
    "name": "MMSE range",
    "category": "RANGE",
    "expected": "10-24 (mild-moderate AD)",
    "actual": "10-24",
    "passed": true,
    "message": "MMSE range: 10 to 24"
  },
  {
    "check": "completion_rate",
    "name": "Overall completion rate",
    "category": "RANGE",
    "expected": "~46% (high dropout in active arms)",
    "actual": "45.7%",
    "passed": true,
    "message": "Overall completion rate: 45.7%"
  },
  {
    "check": "completion_pattern",
    "name": "Completion pattern (Placebo > Active)",
    "category": "CLINICAL",
    "expected": "Placebo ~70%, Active ~35%",
    "actual": "P=66%, XL=32%, XH=38%",
    "passed": true,
    "message": "Placebo should have higher completion than active arms"
  },
  {
    "check": "adas_records",
    "name": "ADAS-Cog records present",
    "category": "LOGICAL",
    "expected": "Multiple timepoints per subject",
    "actual": "923 records",
    "passed": true,
    "message": "ADAS-Cog records: 923"
  },
  {
    "check": "adas_baseline_range",
    "name": "ADAS-Cog baseline range",
    "category": "RANGE",
    "expected": "~10-50 (typical for mild-moderate AD)",
    "actual": "3-62",
    "passed": true,
    "message": "ADAS-Cog baseline: 3 to 62"
  },
  {
    "check": "adas_change_direction",
    "name": "ADAS-Cog change direction",
    "category": "CLINICAL",
    "expected": "Positive (worsening over time)",
    "actual": "Mean change = 0.78",
    "passed": true,
    "message": "ADAS-Cog should worsen over time in placebo/early terminator"
  },
  {
    "check": "cibic_range",
    "name": "CIBIC+ range",
    "category": "RANGE",
    "expected": "1-7 scale",
    "actual": "2-6",
    "passed": true,
    "message": "CIBIC+ range: 2 to 6"
  },
  {
    "check": "ae_rate_pattern",
    "name": "AE rate pattern (Active > Placebo)",
    "category": "CLINICAL",
    "expected": "Active arms should have higher AE rates",
    "actual": "P=64%, XL=55%, XH=69%",
    "passed": false,
    "message": "Active arms should have higher AE rates due to application site reactions"
  },
  {
    "check": "app_site_pattern",
    "name": "Application site AEs (Active >> Placebo)",
    "category": "CLINICAL",
    "expected": "Much higher in active arms",
    "actual": "Placebo: 20, Active: 47",
    "passed": true,
    "message": "Application site AEs are key tolerability signal for transdermal"
  },
  {
    "check": "adqs_subjects_in_adsl",
    "name": "ADQS subjects in ADSL",
    "category": "CROSS_DATASET",
    "expected": "All ADQS subjects in ADSL",
    "actual": "254 subjects in ADQS, 0 missing in ADSL",
    "passed": true,
    "message": "All OK"
  },
  {
    "check": "adae_subjects_in_adsl",
    "name": "ADAE subjects in ADSL",
    "category": "CROSS_DATASET",
    "expected": "All ADAE subjects in ADSL",
    "actual": "159 subjects with AEs, 0 missing in ADSL",
    "passed": true,
    "message": "All OK"
  }
]
